Neoadjuvant nivolumab plus gemcitabine–cisplatin followed by postsurgical adjuvant nivolumab versus neoadjuvant gemcitabine–cisplatin in patients with muscle-invasive bladder cancer: final results from the phase III CA017-078 trial ☆

Annals of Vascular Surgery · Elsevier

Аннотация

Publication date: Available online 23 October 2026 Source: Annals of Oncology Author(s): G. Sonpavde, M.S. van der Heijden, S. Gupta, M.D. Galsky, G. Steinberg, J.E. Gschwend, J.P. Sade, D. Bimbatti, U. De Giorgi, G. Schepisi, S. Vázquez Estévez, S. Panay, G. Schinzari, A. Kotsakis, H. Miyake, J.J. Oh, J. Zhang, C. Jeyamohan, J. Neely, M. Jacques

Читать у издателя →

Похожие статьи